Long-Acting Injectable Antipsychotic To Prevent Relapse in First Episode Schizophrenia
Research published in JAMA Psychiatry demonstrated that long-acting, injectable, second-generation antipsychotic medication has tremendous potential to bring clinical stability to persons with first-episode schizophrenia. According to the authors, “long-acting medications are rarely used following a first episode of schizophrenia.”
Patients …
